11.03.26 -- Navigating Outsourced Pharmaceutical Testing Through Today's Geopolitical Uncertainty

Initial development, scaleup, and tech transfer of complex multi-particulate drug systems requires meticulous planning to mitigate manufacturing risks.

Early design alignment resolves tolerance stack-ups, controls mechanical variation, and more. Navigating process validation and automated assembly accelerates commercialization.

Explore the growing role of highly potent active pharmaceutical ingredients in oncology and Antibody-Drug Conjugates to highlight manufacturing challenges, safety protocols, and opportunities for CDMOs.

Learn how early QC integration, proactive analytical risk management, and cross-functional collaboration can improve validation readiness, reduce development surprises, and more.

High-potency therapies demand stringent containment and worker safety. Discover how scalable, modular infrastructure simplifies compliance and protects product integrity in regulated facilities.

With shifting needs and requirements in advanced therapy manufacturing, embedding infrastructure flexibility is vital. Delve into how to balance these variables for long-term success.

Data Friction stalls critical biopharma decisions and inflates manufacturing risks. Uncover five daily workflows impacted by siloed information and how to build a unified data strategy.

Achieving compliance and safety through Disinfectant Efficacy Studies (DES) is about adhering to regulations and committing to high standards of safety and quality of manufacturing operations.

The updated 2026 PDA Technical Report No. 33 offers a framework for qualifying alternative and rapid microbiological methods against traditional standards for regulatory compliance.

Outdated quality systems delay product release. Take a look at how manufacturers can harness real-time data, operationalize QbD, and enhance compliance, efficiency, and supply chain continuity.

Disconnected files, manual data handling, and missing rationale can weaken CMC handoffs. See where process knowledge commonly gets lost and how connected workflows can reduce rework.

Gain insight into aseptic filling workcells, modalities, agency approvals, and insights from six expert users that offer a peer-driven look at industry innovation and benchmarks.

Optimize drug substance use during fill/finish. Find out how advanced line configurations and 100% non-destructive weight checks mitigate process drift, protect therapeutics, and prevent product loss.

A pioneering perspective shows how new scientific thinking, physics‑based insights, and bold leadership are expanding the druggable universe and opening therapeutic paths once thought impossible.

The move from computerized system validation to assurance reframes how regulated companies adopt digital tools, favoring risk-based critical thinking and quality outcomes over paper-heavy compliance.

Optimizing UHMWPE implants requires balancing materials, processing, and sourcing to improve performance, reduce risk, and lower costs in medical device manufacturing.

AI investment is rising across life sciences, but data challenges stall real-world adoption. Examine what is holding teams back and how to turn AI potential into practical scientific impact.

Leverage proven regulatory expertise and local support to turn China’s rigorous API requirements into a clear, efficient pathway to market success.

Ensuring precision in fill/finish for large-volume devices is critical for performance. Discover the essential traits that redefine innovation and support patient-centric manufacturing solutions.

Solvent recovery can reduce waste, but scaling it brings technical and regulatory risks. Observe how three approaches performed and what it takes to move from bench to commercial scale.

Adopted by leading chemical and pharmaceutical firms, MTP-based ACPP aligns with industry standards, offering portable, easily integrated solutions for continuous, efficient API production needs.